BIOSPECTRUM LIMITED
BIOSPECTRUM LIMITED is a private limited company registered in the United Kingdom, under 11080821, incorporated on 24 November 2017. The company is currently active. Operates in the hospital activities sector (SIC 86101). The company has been operating for 8 years. Registered office address: NG24 3JP Newark, the United Kingdom. Directors include PENELOPE ANN MCQUILKIN, MR STEPHEN MARK ARUNDEL, and TOM NICHLAS ESSNER, and 4 others. Sole shareholder is ADDLIFE LTD. Associated with 12 related entities, including EDGE MEDICAL (BIOLOGICS) LIMITED, XOGRAPH HEALTHCARE LIMITED, and AQUILANT ENDOSCOPY LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
UNIT 9 HALIFAX COURT
FERNWOOD BUSINESS PARK
NOTTINGHAMSHIRE
NG24 3JP NEWARK
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 11080821 | 2026-06-01 | open_in_new |